|
|
 |
 |
 |
|
|
|||
|
||||
|
||||
ACOG's StatementFrom: Efrain Ramirez (eramirez@icepr.com)Fri Sep 29 06:16:52 2000
ACOG NEWS RELEASE September 28, 2000 STATEMENT OF THE AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS ON THE FDA APPROVAL OF MIFEPRISTONE FOR USE WITH MISOPROSTOL IN EARLY ABORTION By W. Benson Harer, Jr., MD ACOG President September 28, 2000 WASHINGTON, DC -- Today's announcement by the Food and Drug Administration brings good news for American women and their physicians. American women choosing to have an abortion have a new option for abortion very early in pregnancy, when it is safest. They finally have access to a drug that has been used safely for many years by other women throughout the world. No longer are American women limited to surgical abortions. Today's decision is a relief for women and their physicians. It should increase the number of physicians offering abortion and enhance the privacy of the abortion decision. Both factors should help reduce the level of violence against physicians and their patients. This decision is long overdue. Clinical trials on thousands of women here and in Europe clearly show that mifepristone when used with misoprostol for early abortion is very safe and effective The American College of Obstetricians and Gynecologists will review and address any restrictions the FDA may have imposed on this drug. But today we emphasize how important the FDA's decision is for women. The FDA is to be commended for doing what is in the best interest of the health and well being of women in the United States. # # # The American College of Obstetricians and Gynecologists is the national medical organization representing over 40,000 physicians who provide health care for women.
-- "Do not take life too seriously. You will never get out of it alive."
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Mon Nov 2 04:45:44 2009 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.